- This topic has 0 replies, 1 voice, and was last updated 1 year, 9 months ago by
.
-
Posts
-
AstraZeneca has one of the biopharmaceutical industry’s most exciting and rapidly expanding Oncology portfolios, spanning both small molecule and biologics research and development. We are developing a comprehensive Oncology portfolio with an emphasis in 4 key platforms: DNA damage repair, Immunotherapy, Tumour Drivers & Resistance and Antibody Drug Conjugates, in 4 core disease areas: Breast, Ovarian, Lung and Hematology.
Several of these drug candidates are targeted therapies that provide benefit to patients with a particular biomarker or genetic mutation, creating a need for concurrent development of companion diagnostics in order to identify patients in a timely manner that can benefit from these therapies.
As the Diagnostic Liaison – Oncology, you will report to the Director, Diagnostics – Oncology, and will be a key leader in building a “best-in-class” Oncology capability at AstraZeneca.
For more information, visit: https://ca.indeed.com/viewjob?jk=4eb92851de94ae13&tk=1g95jfq8lh5ic800&from=serp&vjs=3
- You must be logged in to reply to this topic.